Society and economy are likely to benefit from the advantages of nanotechnology in structural engineering, electronics, optics, consumer products, alternative energy, soil and water remediation, medical uses as therapeutics, diagnostic, or drug delivery devices. Physicist Richard P. Feyman was first who talked about the concept of nanoscience in 1959 in his key lecture at the annual meeting of the American Physical Society, and the term nanotechnology was coined in 1974 by a Japanese researcher Nario Taniguchi to mean "precision machining with tolerance of a micrometer or less". It refers to engineering on the molecular and atomic levels.
Despite bright outlooks for the future of nanotechnology, there is an increasing concern that intentional or unintentional human exposure to some types of engineered nanoparticles may lead to significant adverse health effects (1) . In addition, there is a concern about environmental contamination and associated effects on the ecosystem, which could have significant societal implications. A growing public debate is emerging on whether the environmental and social costs of nanotechnology outweigh its many benefits (2) (3) (4) (5) . The questions about the side effects of products of nanotechnologies are pertinent, since the potential for exposure to nanoparticles will increase as the quantity and types of nanoparticles used in the society grow.
As the outcome of all these debates and concerns, a new branch in toxicological research has emerged with the aim to investigate possible harmful effects of exposure to nanomaterials (6, 7) . Nanotoxicology also encompasses the properties of nanomaterials used in toxicity studies. In addition, nanotoxicology is involved in proposing reliable, robust, and data-assured test protocols for nanomaterials and in human and environmental risk assessment of nanomaterials.
NANOPARTICLES AND THEIR CHARACTERIZATION
Nanoparticles range between 1 nm and100 nm, which is the same size covered by ambient particles which have been termed "ultrafine" particles. Ultrafine particles and engineered nanoparticles have several characteristics in common, but there are also significant differences. Properties of great toxicological importance are common to both. Both consist of primary particles below 100 nm in size, which provide a large surface area per unit mass and potentially high surface reactivity. Both tend to form agglomerates when suspended in gases or liquid, depending on the concentration and the chemistry of the suspension medium. Most of the ambient ultrafine particles are generated as heterogeneous aggregates of primary particles (e. g. combustion soot particles), whereas most of the engineered nanoparticles are generated as monodispersed individual particles (e.g. quantum dots, nanosized TiO 2 , and nanosized ZnO), (Figure 1 and 2).
In theory, nanoparticles can be produced from nearly any chemical, however most nanoparticles that are currently in use have been made from transitional metals, silicon, carbon (single-walled carbon annotates, fullerenes), and metal oxides. In many cases engineered nanoparticles exist as nanocrystals.
By making particles of just a few hundred atoms one creates an enormous amount of surface, which tends to become electrically charged, and thus electro-chemically reactive. Unique electrical and chemical properties make them highly desirable for applications in commercial, medical, environmental and military sectors (8), (Figure 3 ).
Characterization of a dose of nanomaterials for toxicogical investigation is very complex when compared with chemical toxicants. With the latter, the verification of dose or concentration is usually relatively straightforward. It is based on the characterization of composition and purity of the material tested. But with nanoparticles, apart from bulk chemistry, a variety of other material attributes have to be considered, including size and size distribution, shape, crystallinity, porosity, surface roughness, solubility, surface area, state of dispersion, surface chemistry and many other physico-chemical properties (9) . Among all these, four physical parameters are deemed relevant for nanoparticles when assessing their toxicity: particle number, length, surface area, and mass concentration (10) .
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) are gold standards for the evaluation of particle size distribution and shape (Figure 1 and 2 ) in the context of toxicity screening studies. Both provide specific physicochemical information on engineered nanomaterials. 
INTERACTIONS BETWEEN NANOPARTICLES AND BIOLOGICAL SYSTEMS
The main questions scientists are currently facing are: what is the mechanism of toxic action of nanoparticles; how does the reactive surface of nanoparticles interact with "wet internal environment inside the body"; and what is the relative contribution of particle size versus particle composition in the overall toxicity of nanoparticles. Definitive answers to all these questions are currently lacking although research is underway in a number of centres.
Although the chemical composition of nanomaterials is known, rearrangements, for example, of carbon into new polymeric structures, or, similarly, the restructuring of metal oxide or crystalline lattice, are worthy of toxicological considerations. The experiences with the different forms of silica and asbestos have taught us that the physical / chemical properties of materials can be very important determinants of the toxicological potential. The very surface area and quantum chemistry effects that the nanosciences are exploring and hope to manipulate, are also known to be important in determining the manner in which biological systems function and interact with the physical world (11) .
The multitude of available in vitro studies dealing with the mechanism of nanoparticle uptake in different cell types as well as the few studies on in vivo uptake and nanoparticle distribution in animal models demonstrate that there is no single common uptake mechanism for nanoparticles (12, 13) .
The upper size limit for the toxicity of nanoparticles (ultrafine particles) is not fully known, but is thought to lie between 65 nm and 200 nm (14) . In vitro studies performed on cell cultures have confirmed the increased ability of nanoparticles to produce free radicals which can cause cellular damage (15) . Generation of reactive oxygen species (ROS) upon exposure of cells to particulate matter is nowadays considered a major contributor to nanoparticle toxicity. The cell membrane, mitochondria, and cell nucleus are considered relevant for possible nanoparticleinduced toxicity (13), (Figure 1 ). In the light of current knowledge, it seems that the size effect is considerably more important for nanoparticle toxicity than the actual composition of the material. In contrast, in vivo pulmonary inflammation and cytotoxicity studies on rats show that TiO 2 toxicity does not depend on particle size and surface area (29) .
Over the last five years the number of papers on the ongoing work in nanotoxicology has increased exponentially. However, it is still not possible to draw any common conclusion about how nanoparticles interact with biological systems. In different in vivo and in vitro studies the authors find both dose-dependent and dose-independent response to nanoparticles (17) (18) (19) (20) . The type of response is obviously related to the measured parameters. In the same study, some measured parameters may be dose-dependent while others may not. It is interesting and worth mentioning that the highest doses do not necessarily provoke the most pronounced response neither in in vitro nor in in vivo studies.
DEVELOPMENT OF TEST PROTOCOLS FOR NANOMATERIALS
It is not known whether the toxicological assessment of one type and source of nanomaterial will be sufficient to assess the toxicity of the same class/type of nanomaterial produced by a different process. The manufactured materials may also be treated with coatings, or other surface modifications, in order to generate mono-dispersed suspensions that enhance their unique properties. The extent to which surface modifications of intentionally produced nanomaterials affect their toxicity is not known.
In addition, because of the wide variety of properties among nanomaterials, each type can provoke its own unique biological response. As a result, different types of nanomaterials should be categorized, characterized and tested separately, although certain concepts of nanotoxicology based on the small size is likely apply to all nanomaterials (7). The challenge for nanotoxicologists is not to test every variation of a new nanoparticle generated, but instead to identify the key factors that can be used to predict toxicity.
By now, several strategies to screen for the toxicity of nanoparticles have been proposed by various investigators, and discussed in a number of thorough reviews and related documents (5-7, 21-25).
More refined approaches to nanomaterial characterization and toxicological evaluation will emerge with time, but at the moment, the existing test protocols for conventional chemicals are generally recognized as a good starting point. However, these tests have to include additional physical metrics.
Regulatory agencies, professional societies, academic community, NGOs, and industry are involved in developing and validating standard guidelines for toxicity testing strategies of nanomaterials to preempt and avoid unwanted surprises from intentional or unintentional exposures to nanomaterials (5, 25) . These methods have to be timely and cost-effective, and have to provide toxicological information for the diversity of nanomaterials.
HUMAN AND ENVIRONMENTAL RISK ASSESSMENT OF NANOMATERIALS
Risk assessment is the evaluation of scientific information on the hazardous properties of a variety of agents, the dose-response relationship, and the extent of exposure of humans or environmental targets to these agents. The product of risk assessment is a statement about the likelihood of exposed humans and the ecosystem with all its components being harmed and to what degree (risk characterization).
The following key aspects of risk assessment are addressed, as they relate to nanomaterials: a) identification of chemical and physical properties; b) environmental fate; c) environmental detection and analysis; d) human and ecosystem exposure; and e) human and ecosystem effects (5, 22, 25, 26) . a) Identification and characterization of chemical substances and materials is an important first step in assessing their risk. The diversity and complexity of nanomaterials makes chemical identification and characterization more difficult than with other chemicals. A broader spectrum of properties will be needed to sufficiently characterize a given nanomaterial, evaluating the hazard and assess the risk. b) Fundamental properties concerning the environmental fate of nanomaterials are not well understood. Models used to assess the environmental fate and exposure to conventional chemicals are not applicable to intentionally produced nanomaterials. Depending on the relevance of chemical properties or transformation, new models may have to be developed to provide estimations for new materials. However, a certain amount of reliable experimental data must be acquired before the environmental fate, transport, and multimedia partitioning of nanomaterials can be effectively modelled.
c) The challenge in detecting nanomaterials in the environment is compounded not only by the extremely small size of the particles, but also by their unique physical structure and physico-chemical characteristics. The variety of physical and chemical properties can significantly affect the extraction and analytical techniques that can be used for the analyses of a specific nanomaterial.
There is a range of methods available for measuring nanostructured aerosol number, surface area, and mass concentration, although only a few of these are directly applicable to monitoring exposure to nanostructured aerosols. Maynand et al. (27) have proposed a universal aerosol sampler that would log exposure against aerosol number, surface area and mass concentration simultaneously.
In liquid media, the available technologies for size fractionation and collection of nanoparticle fractions include size-exclusion chromatography, ultrafiltration, and field-flow fractionation (9) .
For more definitive analytical data, single-particle analytical techniques can be employed. Single particle laser microscope mass spectrometry (LAMMS) can provide chemical composition data on single particles from a collected fraction (28) . Electron microscopy techniques can provide particle size, morphological and chemical composition information for a single nanoparticle (Figure 1 ).
It will be necessary to monitor products that incorporate nanoparticles and nanofibres throughout their life, from manufacture to disposal, in order to estimate the probability of environmental emissions, particularly from disposal and waste management processes.
d) Human and ecosystem exposure account for a series of events beginning with external mechanisms that make a chemical / nanoparticle available for absorption or other mode of entry and ending with the chemical or its metabolite reaching the target organ, depending on the nature of the chemical and route of exposure. There are several tools to assess exposure, including monitoring data, exposure models, and the use of analogous data for the existing chemicals, summarized in the US Environmental Protection Agency Nanotechnology White Paper 2007 (5) . e) Assessing nanomaterial toxicity is extremely complex and multifunctional, and is potentially influenced by a variety of physico-chemical properties of nanoparticles. At the moment, there is a significant gap in our knowledge of the environmental, health and ecological implications associated with nanotechnology. However, an exponential increase in scientific papers over the last five years reflects the ongoing work and the importance of this area (1) .
Human and environmental risk assessment of nanomaterials will be the central goal of nanotoxicology in the future. Only through development of a sound evidence base in all aspects of hazard and exposure assessment can we hope to generate an informed and reliable risk assessment of nanoparticles. Risk assessment is of key importance to the insurance industry as well as the regulatory agencies that are responsible for formulating exposure and safety guidelines. Some suggest that REACH's applicability to nanoparticles and nanomaterials is unclear. While it is true that REACH does not specifically mention nanoparticles or nanoscale materials anywhere in its eight hundred plus pages of text, both the restriction and authorization processes can also be applied to substances produced or imported in volumes below one tonne per year. If substances in the nano-scale fall under the scope of REACH, their health and environment properties must therefore be assessed following the provisions of this Regulation. However, the methodologies for identifying hazards and evaluating risks of substances at the nano-scale need to be further refined in years to come. It is important to stress that engineered nanoparticles have to be treated as new substances as defined by REACH, and not as "a refinement of particle size distribution". At present, laboratory guidelines or national chemicals policies do not distinguish between handling nano-or macroparticles.
REGULATION OF ENGINEERED NANOMATERIALS IN EUROPE
The US EPA has also suggested that the overall risk approach for conventional chemicals is generally also applicable to nanomaterials (5) .
Environmental and health dangers posed by synthetic nanoparticles require that the following actions are taken in the near future: a) establishment of national and international interdisciplinary research centres to study the potential hazards of synthetic nanoparticles; b) establishment of a central information office for the general public; and c) establishment of public dialogue on the opportunities and risks posed by synthetic nanoparticles.
CONCLUDING REMARKS
According to some estimates, nanotechnology promises to far exceed the impact of the Industrial Revolution and is projected to become a US$ 1 trillion market by 2015.
The importance of nanotechnologies to our well being is beyond debate, but its potential adverse impacts need to be studied all the more. Nanotoxicology as a new discipline should make an important contribution to the development of a sustainable and safe nanotechnology.
An improved understanding of the risk factors related to nanomaterials in the human body and the ecosystem will aid future development and exploitation of a variety of nanomaterials.
Issues related to new nanoparticles are in the headlines due to the fear of their escaping into the environment. In fact, we have lived with sub-micron sized particles around us forever. The introduction of man-made versions has just brought to light the fact how little we know about their toxic effects.
Awareness is growing about the need to develop an infrastructure for characterizing and measuring nanomaterials in complex matrices and for developing reference materials, both for calibration of instruments used for assessing exposure and dosimetry, and for benchmarking toxicity tests. Public expects that new or emerging technologies meet higher safety requirements than tried and tested technologies. Failure to meet these requirements may result in public fear or even rejection of nanotechnology-based products, which often essentially improve the quality of life of individuals, groups of people, or even nations.
